Related Experiment Videos
Nitric oxide and glomerulonephritis
1Department of Pediatrics, Schneider Children's Hospital of Long Island Jewish Medical Center, Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, New York 11040, USA. trachtma@lij.edu
Seminars in Nephrology
|July 15, 2004
Summary
Nitric oxide (NO) plays a dual role in glomerulonephritis, an immune-kidney injury. While excessive NO from inducible nitric oxide synthase (iNOS) worsens kidney damage, NO from endothelial nitric oxide synthase (eNOS) may be protective.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Glomerulonephritis involves immune-mediated kidney injury, impairing the glomerular filtration barrier.
- Nitric oxide (NO) is investigated for its role as an inflammatory mediator in kidney disease.
- NO can directly cause glomerular injury or exacerbate it by stimulating other inflammatory mediators.
Purpose of the Study:
- To evaluate the role of nitric oxide (NO) in the pathogenesis of glomerulonephritis.
- To differentiate the effects of NO produced by different nitric oxide synthase (NOS) isoforms in experimental glomerulonephritis models.
- To assess the potential of targeting NO pathways for therapeutic interventions in glomerulonephritis.
Main Methods:
- Review of experimental models of glomerulonephritis (e.g., Thy1.1 nephritis, Heymann nephritis).
- Analysis of nitric oxide (NO) production and its association with glomerular injury markers.
- Evaluation of interventions targeting inducible nitric oxide synthase (iNOS) and assessment of nitric oxide (NO) derived from endothelial nitric oxide synthase (eNOS).
Main Results:
- Increased NO production is consistently observed in experimental glomerulonephritis models.
- Excessive NO from iNOS correlates with enhanced glomerular injury and proteinuria.
- Inhibition of iNOS reduces proteinuria and glomerular damage, while eNOS-derived NO may offer protection.
Conclusions:
- Nitric oxide (NO) acts as a pro-inflammatory mediator in glomerulonephritis, primarily through iNOS.
- NO derived from eNOS may have protective effects on glomerular endothelial cells.
- Further research is needed to clarify the role of NO in human glomerulonephritis and develop targeted therapies.